ArticlePloS one2026
Changes in life expectancy and life span equality during the COVID-19 epidemic in 2020-22 in Japan.
Article in PloS one, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Demographic Analysis of Mortality Changes Associated With the COVID-19 Pandemic in Japan, 2020-2022.Influenza and other respiratory viruses · 2025Article
- Estimating changes in life expectancy in Hong Kong during the COVID-19 pandemic: a longitudinal ecological study.The Lancet regional health. Western Pacific · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectivesLife expectancy at birth is a demographic measure derived from age-specific mortality rates, reflecting the population's mortality pattern and its changes over time. While life expectancy has been heavily applied to quantify the mortality impact of the COVID-19 pandemic, the present study not only decomposes the changes in life expectancy by age and cause of death but also assesses the shifts in the age pattern of mortality in Japan. With this aim, we first evaluated the relationship between life expectancy gap from 2020-21 and 2021-22 and indicators of COVID-19 epidemic size at prefectural level. We also conducted age- and cause-specific decomposition of life expectancy change. Trends of life span equality from 2000-22 were also evaluated at the national level. Prefectural analysis between 2021-22 life expectancy change and annual per-population COVID-19 cases, person days in intensive care, reported COVID-19 deaths did not reveal significant correlations, which was contrary to our analysis from 2020-21. However, decomposition analysis revealed substantial life expectancy shortening attributable to the over-35-year-old population, and large increases in death causes such as cardiovascular or respiratory disorders along with COVID-19. For the total population in Japan, life span equality, an inverse measure of the dispersion in ages at death (higher values indicate less variation), declined in 2020 but increased in 2021 and 2022 despite the shortening in life expectancy. There were several key findings in this work. First, the discrepancy between life expectancy change and COVID-19 statistics in 2022 may, among other factors, possibly be attributable to the growing ascertainment bias of COVID-19. Second, the increased contribution of cardiovascular disorders to life expectancy shortening is an alarming sign for the future. Third, Life span equality in 2021 and 2022 is likely attributed to increased mortality among the elderly.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.